{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:29:14Z","timestamp":1760956154330,"version":"3.40.5"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Healthcare providers (HCPs) may face numerous dilemmas in optimally screening, diagnosing, and treating patients with, and\/or at risk for, hepatocellular carcinoma (HCC). This study aimed to achieve a greater understanding of the challenges in HCC care which in turn could delineate HCP educational opportunities within this oncologic sub\u2010specialty.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A mixed\u2010methods approach was used to identify practice gaps and clinical barriers experienced by US\u2010based medical oncologists, hepatologists, oncology physician assistants, oncology nurse practitioners, and interventional radiologists involved in HCC care. The qualitative (semi\u2010structured interview) and quantitative (survey) data collection approaches were deployed sequentially with findings subsequently triangulated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 214 HCPs participated in this study. Analysis revealed challenges related to screening and diagnosing HCC, specifically in applying appropriate screening guidelines, and the optimal use and decisions related to diagnostic imaging and biopsy. Issues related to treatment selection included the application of existing HCC guidelines in treatment decision\u2010making, weighing risk\/benefit ratios of various antineoplastics regimens (i.e., tyrosine kinase inhibitors\u2010TKIs, immunotherapy agents, chemotherapy), sequencing therapies, potential toxicity management, and optimally educating patients about their HCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings highlight the educational needs of those involved in HCC care and provide a starting point for clinicians to both reflect on their practice and identify opportunities to enhance communication within the HCC team and between provider and patient. There is an opportunity to optimize continuing professional development interventions that address the identified gaps in clinical practice specifically related to teamwork and interdisciplinary communication.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cam4.5216","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T09:27:56Z","timestamp":1663234076000},"page":"3670-3683","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals"],"prefix":"10.1002","volume":"12","author":[{"given":"Ginny","family":"Jacobs","sequence":"first","affiliation":[{"name":"AXDEV Global Inc.  Virginia Beach Virginia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Boyle","sequence":"additional","affiliation":[{"name":"Advanced Oncology Nursing Resources  Phoenix Arizona USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashem B.","family":"El\u2010Serag","sequence":"additional","affiliation":[{"name":"Texas Medical Center Digestive Diseases Center Houston  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Northwestern Memorial Hospital, Department of radiology  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Yale School of Medicine  New Haven Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9278-1718","authenticated-orcid":false,"given":"Patrice","family":"Lazure","sequence":"additional","affiliation":[{"name":"AXDEV Group Inc.  Brossard Quebec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pam","family":"McFadden","sequence":"additional","affiliation":[{"name":"AXDEV Global Inc.  Virginia Beach Virginia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00001"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32723"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14843"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.010"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05537-2"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09995-8"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/878763"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.025"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S61146"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000499765"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.02.003"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.03.014"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.2217\/hep-2018-0002"},{"key":"e_1_2_11_16_1","first-page":"347","article-title":"Stereotactic body radiation therapy vs. transarterial chemoembolization in inoperable Barcelona clinic liver cancer stage a hepatocellular carcinoma: a retrospective, propensity\u2010matched analysis. Front","volume":"10","author":"Su T\u2010S","year":"2020","journal-title":"Oncologia"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0758"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693512"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3544"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15169"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1094428115610808"},{"key":"e_1_2_11_22_1","unstructured":"ICC\/ESOMAR.ICC\/ESOMAR (International Chamber of Commerce\/European Society for Opinion and Marketing Research) International code on market opinion and social research and data analytics2016. Available from URL:https:\/\/www.esomar.org\/what\u2010we\u2010do\/code\u2010guidelines."},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2018-105140"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-013-0528-y"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/1744987117741667"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/135581960501000110"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.03.027"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2016.22.1.7"},{"issue":"1443","key":"e_1_2_11_29_1","article-title":"Validation of the updated hepatocellular carcinoma early detection screening algorithm in a community\u2010based cohort of patients with cirrhosis of multiple etiologies","volume":"19","author":"Tayob N","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228857"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S300182"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.07.029"},{"key":"e_1_2_11_33_1","first-page":"1","article-title":"Diagnostic and therapeutic delays in patients with hepatocellular carcinoma","volume":"1","author":"Rao A","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.07.026"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12580"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.040"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030584"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S279858"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2020.11.001"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2018.0636"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06347-w"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07559-1"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0715"},{"key":"e_1_2_11_44_1","unstructured":"FDA approves atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma. Available from URL:https:\/\/www.fda.gov\/drugs\/resources\u2010information\u2010approved\u2010drugs\/fda\u2010approves\u2010atezolizumab\u2010plus\u2010bevacizumab\u2010unresectable\u2010hepatocellular\u2010carcinoma."},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1719178"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S104807"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2014-101946"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i34.7645"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.21037\/aes.2017.04.01"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.5216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.5216","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.5216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T08:26:54Z","timestamp":1732523214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.5216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1002\/cam4.5216"],"URL":"https:\/\/doi.org\/10.1002\/cam4.5216","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"type":"print","value":"2045-7634"},{"type":"electronic","value":"2045-7634"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"2022-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}